4.6 Article

PLASMA OXYTOCIN IMMUNOREACTIVE PRODUCTS AND RESPONSE TO TRUST IN PATIENTS WITH SOCIAL ANXIETY DISORDER

Journal

DEPRESSION AND ANXIETY
Volume 29, Issue 11, Pages 924-930

Publisher

WILEY
DOI: 10.1002/da.21973

Keywords

social anxiety disorder; oxytocin; trust; neuropeptide

Funding

  1. Harvard-MIT Health Sciences and Technology/Beth Israel Deaconess Medical Center
  2. Pfizer Inc.
  3. MerckMerck and Company, Inc.
  4. Eli Lilly, Inc
  5. John Templeton Foundation
  6. Harvard Catalyst: The Harvard Clinical and Translational Science Center (NIH) [UL1 RR 025758]
  7. Harvard University
  8. Bristol Myers Squibb
  9. Euthymics
  10. Forest Laboratories
  11. GlaxoSmithKline
  12. Eli Lilly
  13. Sepracor
  14. American Foundation for Suicide Prevention
  15. NARSAD
  16. Lilly
  17. Pfizer

Ask authors/readers for more resources

Background: Generalized Social Anxiety Disorder (GSAD) is characterized by excessive fear and avoidance of several types of social and performance situations. The pathophysiology is not well understood, but research in animals and humans has provided evidence that oxytocin helps regulate normal social affiliative behavior. Previous work in healthy male subjects demonstrated a rise in plasma oxytocin after receiving a high trust signal. To examine the oxytocin system in GSAD, we measured plasma oxytocin in GSAD patients and controls, before and after the social Trust Game, a neuroeconomic test examining trust behavior and reaction to trust using real monetary incentives. Methods: Thirty-nine subjects with GSAD and 28 healthy controls provided three blood samples for oxytocin measurement before the Trust Game, and one sample after the game. Plasma estradiol was also measured at baseline. The Trust Game protocol version prioritized the sending of a signal of high cooperation and trust to all participants. All analyses controlled for gender and estradiol levels. Results: Mean oxytocin levels post-Trust Game (P = .025), and overall (area under the curve, P = .011) were lower in GSAD patients compared to controls, after controlling for sex and estradiol. There was no significant change in oxytocin levels after the game in either group. Conclusions: We report low plasma oxytocin levels in patients with GSAD during a prosocial laboratory task paradigm. Additional research will be important to further examine the relationship between oxytocin and social behavior in GSAD. Depression and Anxiety 29:924-930, 12012. (c) 2012 Wiley Periodicals, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available